FDA Approval Activities for this Drug
Viagra (Sildenafil Citrate) Tablets, Viagra Information Page Pfizer, NDA 20-895/S11, S15 & S18 9/19/02 10/2/02 9/20/02
Viagra (Sildenafil Citrate) Tablets, Viagra Information Page Pfizer NDA 20-895 | Revatio (Sildenafil Citrate) Tablet, Pfizer, Approval | Viagra (sildenafil citrate), Pfizer, Labeling Revision | Revatio (sildenafil citrate) Tablets, Pfizer Inc., Labeling Revision | Viagra (sildenafil citrate), Pfizer Inc., Labeling Revision | Revatio (sildenafil citrate) Tablets, Pfizer Inc., Labeling Revision | Revatio (sildenafil citrate) Tablets, Pfizer, Labeling Revision | Viagra (sildenafil citrate), Pfizer, Inc., Labeling Revision | Sildenafil Citrate Tablets, Teva Pharma, Tentative Approval | Sildenafil Citrate Tablets, Teva Pharma, Tentative Approval | VIAGRA (sildenafil citrate) Tablets, Pfizer Inc., Labeling Revision | Revatio (sildenafil citrate) Tablets, Pfizer Inc., Labeling Revision | VIAGRA (sildenafil citrate) Tablets, Pfizer Inc., Labeling Revision | Viagra (sildenafil citrate) Tablets, Pfizer, Inc., Labeling Revision